Skip to main content

Maximize Efficacy and Minimize Risk with Pronalyse’s Gene Therapy Product Characterization Services

Based on years of experience supporting protein characterization research, Creative Proteomics Pronalyse has launched the Gene Therapy Products Characterization service, aiming to provide researchers and developers with the tools and resources necessary for successful gene therapy product development.

Shirley, New York, United States - April 26, 2023

Pronalyse is a subdivision of Creative Proteomics, an integrated CRO company with rich experience in providing drug development services. Based on years of experience supporting protein characterization research, Creative Proteomics Pronalyse has launched the Gene Therapy Products Characterization service, aiming to provide researchers and developers with the tools and resources necessary for successful gene therapy product development.

Gene therapy is a promising field that has the potential to treat a wide range of diseases, including genetic disorders, cancer, and viral infections. However, developing successful gene therapy products requires a thorough understanding of the molecular and functional characteristics of the therapeutic gene product. This is where Creative Proteomics’ Gene Therapy Products Characterization Services come in, providing a comprehensive characterization of gene therapy products to ensure the safety and efficacy of the final product.

“Our Gene Therapy Products Characterization Services are designed to help our clients achieve the highest quality gene therapy products,” said the Senior Scientist of Creative Proteomics. “With our state-of-the-art equipment and expertise, we can provide a complete characterization of gene therapy products, including structural analysis, purity assessment, and bioactivity testing.”

“Gene therapy is a complex and challenging field, and successful product development requires a deep understanding of the molecular and functional characteristics of the therapeutic gene product. At Creative Proteomics, we are committed to providing our clients with the tools and resources they need to develop safe and effective gene therapy products.” he further added.

Creative Proteomics' Gene Therapy Products Characterization Services are essential for a wide range of gene therapy applications, including viral vectors, plasmid DNA, mRNA, and gene editing tools. These services are critical for the development of safe and effective gene therapies, as they provide researchers and developers with the information they need to optimize their products for maximum efficacy and safety.

About Creative Proteomics

Creative Proteomics is an innovative contract research organization that focuses on using advanced equipment platforms and optimized detection technology to help researchers around the world reduce time and costs. The company has a proprietary laboratory information management system to strengthen laboratory quality monitoring and management, ensuring the efficiency and security of customer data.

Contact Info:
Name: Dora West
Email: Send Email
Organization: Creative Proteomics
Website: https://www.creative-proteomics.com/

Release ID: 89095830

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.